Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8769
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America
Carlos Franco-Muñoz
Diego Alejandro Alvarez-Diaz
Katherine Laiton-Donato
Magdalena Wiesner
Patricia Escandón
Jose Usme_Ciro
Nicolás David Franco Sierra
Astrid Carolina Flórez Sánchez
Sergio Yebrail Gómez-Rangel
LUZ DARY RODRIGUEZ
JULIANA BARBOSA RAMIREZ
Erika Ximena
Diana M. Walteros
Martha L Martínez
Marcela Mercado-Reyes
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.1101/2020.06.02.20120782
https://www.medrxiv.org/content/10.1101/2020.06.02.20120782v2
SARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemic. The virus crossed the species barrier and established in the human population taking advantage of the spike protein high affinity for the ACE receptor to infect the lower respiratory tract. The Nucleocapsid (N) and Spike (S) are highly immunogenic structural proteins and most commercial COVID-19 diagnostic assays target these proteins. In an unpredictable epidemic, it is essential to know about their genetic variability. The objective of this study was to describe the substitution frequency of the S and N proteins of SARS-CoV-2 in South America. A total of 504 amino acid and nucleotide sequences of the S and N proteins of SARS-CoV-2 from seven South American countries (Argentina, Brazil, Chile, Ecuador, Peru, Uruguay, and Colombia), reported as of June 3, and corresponding to samples collected between March and April 2020, were compared through substitution matrices using the Muscle algorithm in MEGA X. Forty-three sequences from 13 Colombian departments were obtained in this study using the Oxford Nanopore and Illumina MiSeq technologies, following the amplicon-based ARTIC network protocol. The substitutions D614G in S and R203K/G204R in N were the most frequent in South America, observed in 83% and 34% of the sequences respectively. Strikingly, genomes with the conserved position D614 were almost completely replaced by genomes with the G614 substitution between March to April, 2020. A similar replacement pattern was observed with R203K/G204R although more marked in Chile, Argentina and Brazil, suggesting similar introduction history and/or control strategies of SARS-CoV-2 in these countries. It is necessary to continue with the genomic surveillance of S and N proteins during the SARS-CoV-2 pandemic as this information can be useful for developing vaccines, therapeutics and diagnostic tests.
bioRxiv
16-06-2020
Preimpreso
Inglés
Público en general
VIRUS RESPIRATORIOS
Versión publicada
publishedVersion - Versión publicada
Aparece en las colecciones: Materiales de Consulta y Comunicados Técnicos

Cargar archivos: